Form 10 Explorer
10-Q
Quarterly Report
BIO KEY INTERNATIONAL INC

BKYI

NASDAQ

CIK: 1019034

File #: 1-13463

Period End: Jun 30, 2025

Fiscal Year: 2025

View on EDGAR
Balance Sheet
40 line items · 2 periods
XBRL
ItemJun 30, 2025Dec 31, 2024
ASSETS
Cash and cash equivalents
2,275,344437,604
Accounts receivable, net
983,534718,229
Due from factor
154,76974,170
Inventory
318,538378,307
Prepaid expenses and other
303,045278,648
Total current assets
4,035,2301,886,958
Equipment and leasehold improvements, net
102,499140,198
Capitalized contract costs, net
367,125409,426
Deposits and other assets
7,9767,976
Operating lease right-of-use assets
60,82973,372
Approximation
60,82973,372
Investments
5,000,0005,000,000
Intangible assets, net
942,8921,097,630
Total non-current assets
6,481,3216,728,602
TOTAL ASSETS
10,516,5518,615,560
LIABILITIES
Accounts payable
889,026818,187
Accrued liabilities
1,170,8891,278,732
Senior Secured Promissory Note
447,1531,525,977
Government Loan
125,562132,731
Deferred revenue, current
873,394773,267
Operating lease liabilities, current portion
25,88624,642
Total current liabilities
3,531,9104,553,536
Deferred revenue, long term
96,729196,237
Government loan – BBVA Bank – net of current portion
044,762
Operating lease liabilities, net of current portion
35,73548,994
Total non-current liabilities
132,464289,993
TOTAL LIABILITIES
3,664,3744,843,529
STOCKHOLDERS’ EQUITY
Common stock — authorized, 170,000,000 shares; issued and outstanding; 6,848,776 and 3,715,483 of $.0001 par value at June 30, 2025 and December 31, 2024, respectively
685372
Additional paid-in capital
137,948,437133,030,271
Accumulated other comprehensive income
114,89849,290
Accumulated deficit
(131,211,843)(129,307,902)
TOTAL STOCKHOLDERS’ EQUITY
6,852,1773,772,031
Common Stock
685372
Additional Paid-in Capital
137,948,437133,030,271
AOCI Attributable to Parent
114,89849,290
Retained Earnings
(131,211,843)(129,307,902)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
10,516,5518,615,560